VIP   Click here for help

GtoPdb Ligand ID: 1152

Immunopharmacology Ligand
Comment: Sequences of human, mouse and rat VIP are identical

VIP was first isolated and sequenced from pig small intestine [12,15].

As with many peptide molecules, there is ambiguity surrounding representations of the exact stereochemistry of VIP. The structure shown here does not specify stereochemistry.
Species: Human, Mouse, Rat
Click here for help
IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: vasoactive intestinal peptide

2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
Isomeric SMILES NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CC(=O)N)CC(C)C)C(CC)C)CO)CC(=O)N)CC(C)C)Cc1ccc(cc1)O)CCCCN)CCCCN)C(C)C)C)CCSC)CCC(=O)N)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(O)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(Cc1nc[nH]c1)N)CO)CC(=O)O)C)Cc1ccccc1)CC(=O)O)CC(=O)N)Cc1ccc(cc1)O)CCCNC(=N)N)CC(C)C)CCCNC(=N)N
InChI InChI=1S/C147H237N43O43S/c1-18-75(12)115(142(229)180-96(56-72(6)7)131(218)183-104(145(232)233)63-110(155)200)188-139(226)106(68-192)185-134(221)101(62-109(154)199)177-130(217)95(55-71(4)5)174-132(219)97(58-81-37-41-84(195)42-38-81)175-125(212)88(33-23-26-49-149)167-123(210)89(34-24-27-50-150)171-140(227)113(73(8)9)186-118(205)76(13)164-121(208)93(47-53-234-17)170-127(214)92(45-46-107(152)197)169-122(209)87(32-22-25-48-148)166-124(211)90(35-28-51-161-146(156)157)168-129(216)94(54-70(2)3)173-126(213)91(36-29-52-162-147(158)159)172-143(230)116(78(15)193)189-136(223)98(59-82-39-43-85(196)44-40-82)176-133(220)100(61-108(153)198)178-135(222)103(65-112(203)204)182-144(231)117(79(16)194)190-137(224)99(57-80-30-20-19-21-31-80)181-141(228)114(74(10)11)187-119(206)77(14)165-128(215)102(64-111(201)202)179-138(225)105(67-191)184-120(207)86(151)60-83-66-160-69-163-83/h19-21,30-31,37-44,66,69-79,86-106,113-117,191-196H,18,22-29,32-36,45-65,67-68,148-151H2,1-17H3,(H2,152,197)(H2,153,198)(H2,154,199)(H2,155,200)(H,160,163)(H,164,208)(H,165,215)(H,166,211)(H,167,210)(H,168,216)(H,169,209)(H,170,214)(H,171,227)(H,172,230)(H,173,213)(H,174,219)(H,175,212)(H,176,220)(H,177,217)(H,178,222)(H,179,225)(H,180,229)(H,181,228)(H,182,231)(H,183,218)(H,184,207)(H,185,221)(H,186,205)(H,187,206)(H,188,226)(H,189,223)(H,190,224)(H,201,202)(H,203,204)(H,232,233)(H4,156,157,161)(H4,158,159,162)
InChI Key VBUWHHLIZKOSMS-UHFFFAOYSA-N

For advanced searching click here to open chemical structure editor

Related Sequences Click here for help
PHI  {Sp: Pig}
Targets
VPAC1 receptor; VPAC2 receptor
PHM  {Sp: Human}
Targets
PAC1 receptor; VPAC1 receptor
PHV  {Sp: Rat}
Targets
PAC1 receptor; VPAC1 receptor; VPAC2 receptor
PHV  {Sp: Human}
Targets
PAC1 receptor
PHI  {Sp: Mouse, Rat}
Targets
PAC1 receptor; VPAC1 receptor; VPAC2 receptor
Other Similar Sequences Click here for help
Ro 25-1553
Targets
PAC1 receptor; VPAC1 receptor; VPAC2 receptor
BAY 55-9837
Targets
PAC1 receptor; VPAC1 receptor; VPAC2 receptor
N-stearyl-[Nle17]VIP
Targets
VPAC1 receptor; VPAC2 receptor
PG 99-465
Targets
PAC1 receptor; VPAC1 receptor; VPAC2 receptor
Ro 25-1392
Targets
VPAC1 receptor; VPAC2 receptor
[125I]VIP (human, mouse, rat)
Targets
PAC1 receptor; VPAC1 receptor; VPAC2 receptor
[125I]BAY 55-9837
Targets
VPAC2 receptor
aviptadil
Structurally Similar Ligands Click here for help
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page
Click here for ligand page